Board of Directors

A.J. Kazimi
Chairman and Chief Executive Officer

Mr. Kazimi has over twenty years’ experience in the international biopharmaceutical industry. He has served as Chief Executive Officer and Chairman of the Board of Directors of Cumberland Pharmaceuticals, a specialty pharmaceutical firm headquartered in Nashville since the Company’s inception in 1999. The Company was twice named to the Inc. 500 list of fastest growing private firms in the U.S. prior to its Initial Public Offering and listing on the NASDAQ stock exchange in 2009. More recently Cumberland was named one of the 40 fastest growing healthcare companies headquartered in the U.S. by Modern Healthcare Magazine in a listing that included hospital, physician, payers/insurers and supplier companies of all sizes.

Prior to forming Cumberland, Mr. Kazimi served as President and Chief Operating Officer of Therapeutic Antibodies Inc., an international biopharmaceutical company. During his eleven years with the company, he oversaw operations in three countries and played a key role in the company's product development programs and licensing agreements. During his tenure the company completed over $100 million in financings culminating in an IPO on the London stock exchange. Earlier in his career, he worked at Brown-Forman Corporation, a Fortune 500 company rising through a series of management positions.

Mr. Kazimi currently serves on the board of directors for the Nashville Health Care Council and Nashville Sports Council. He also serves as Chairman of CET a biomedical incubator and joint initiative among Cumberland, Vanderbilt University and the state of Tennessee’s Technology Development Corporation He has previously served on the boards of the Tennessee Biotechnology Association and Aegis Sciences Corporation, a federally certified forensic toxicology laboratory. He holds a B.S. from the University of Notre Dame and an M.B.A. from the Vanderbilt Owen Graduate School of Management.



Gordon R. Bernard, M.D.
Director

Dr. Bernard served as our Medical Director from 1999 until 2010 and currently serves as an advisor to the Company as Chair of our Medical Advisory Board. He has served on our Board of Directors since 2010. Dr. Bernard is the Associate Vice-Chancellor for Research at Vanderbilt University, and also the Melinda Owen Bass Professor of Medicine and former Chief of the Division of Allergy, Pulmonary and Critical Care Medicine at Vanderbilt. In addition, he is Senior Associate Dean for Clinical Sciences and Chairman of Vanderbilt’s Pharmacy and Therapeutics Committee, which is responsible for approving the Vanderbilt Medical Center Formulary of approved drugs and therapeutics. Dr. Bernard has been conducting national and international trials of pharmaceuticals since 1980 and he has been steering committee chair of the National Institutes of Health, Acute Respiratory Distress Syndrome Clinical Trials Network since its inception in 1994. This network is the only federally supported ongoing system for the conduct of research in the hospital Intensive Care Unit, or ICU. He holds a B.S. from the University of Southwestern Louisiana and an M.D. from Louisiana State University. Dr. Bernard maintains an active practice as an Intensivist in the Medical ICU at Vanderbilt and is therefore in a position to observe, first hand, the pharmaceutical management issues surrounding the care of a wide variety of the most severely ill patients and identify their unmet medical needs. The Board believes Dr. Bernard’s medical background is extremely valuable as the Company seeks to continue expanding its pipeline with promising products that offer advancement to patient care and are well-positioned competitively.



Martin E. Cearnal
Executive Vice President & Chief Commercial Officer

Prior to joining Cumberland as Senior Vice President of Commercial Development in 2008, Mr. Cearnal served as President and Chief Executive Officer of Physicians World. During his 15-year tenure, the company became the largest provider of continuing medical education before its acquisition by Thomson Healthcare in 2000. He served as President of Thomson Physicians World from 2000 to 2003 and Executive Vice President-Chief Strategy Officer for Thomson Medical Education from 2003 through 2005. During his more than 44 years in the healthcare industry, Mr. Cearnal has been involved with the launches of such noteworthy pharmaceutical products as Lipitor®, Actos®, Intron-A®, Straterra®, Botox®, and Humira®. He spent 17 years at Revlon Healthcare in a variety of domestic and international pharmaceutical marketing roles, culminating in his position as Vice President, Marketing for International Operations. Mr. Cearnal has also served on Cumberland’s Board of Directors since 2004. He is a graduate of Southeast Missouri State University.



Jonathan Griggs
Director

Mr. Griggs has served as a member of our Board of Directors since 2010. His career spans more than 40 years in the pharmaceutical and biotechnology industries and includes significant international experience. He spent 23 years at Warner Lambert Corporation in positions of increasing responsibility, culminating with his position as Vice President of Human Resources. During his tenure with Warner Lambert, he provided leadership for the successful integration of three pharmaceutical businesses into what became Parke Davis, the largest consolidation in the industry at that time. From 1992 to present he has been the CEO of Griggs & Associates, a management and human resources consulting firm assisting start-up companies and providing critical assistance in turnaround situations. Mr. Griggs also provided the leadership and strategic management for the formation and establishment of the AACA (Antique Auto Club of America) Museum, a leading transportation museum where he served as chairman and is currently a director. Mr. Griggs has his B.S. Degree from Penn State and attended the Wharton School of Management at the University of Pennsylvania. He has been an advisor to Cumberland Pharmaceuticals as a member of the Company’s Pharmaceutical Advisory Board since it began operations in 1999. The Board believes Mr. Griggs’ experience in strategic management and human resources consulting will be critical as the Company continues to build a strong, effective management team.



Joey Jacobs
Director

 Mr. Jacobs joined Cumberland’s Board of Directors in 2011 and is a member of the Nominating Committee. A healthcare veteran with more than 35 years of industry experience, Mr. Jacobs is currently the Chairman and Chief Executive Officer of Acadia Healthcare, a rapidly growing behavioral health company. Mr. Jacobs is the former Chairman, President and Chief Executive Officer of Nashville-based Psychiatric Solutions, Inc. (PSI), which he co-founded in 1997 and grew into a $2 billion behavioral healthcare system before the company’s sale to Universal Health Services in 2010. Prior to founding PSI, Mr. Jacobs spent 21 years at Hospital Corporation of America, or HCA, where he served in various capacities, including President of HCA’s Tennessee Division. Mr. Jacobs’ background at HCA also includes serving as President of HCA’s Central Group, Vice President of the Western Group, Assistant Vice President of the Central Group and Assistant Vice President of the Salt Lake City Division. In addition to serving as the former Chairman of the Nashville Health Care Council, he is also the past director of the Federation of American Hospitals and the National Association of Psychiatric Health Systems. He is currently a board member of the Monroe Carell, Jr. Children’s Hospital at Vanderbilt and Mental Health Management. Mr. Jacobs holds a B.S. degree from Middle Tennessee State University. The Board believes Mr. Jacobs’ extensive hospital industry experience as well as his prior experience as chairman and CEO of a publicly traded healthcare company will be critical as the Company continues to develop its hospital acute care product line and navigate the responsibilities associated with being a



James Jones
Director

Mr. Jones has served as a member of our Board of Directors since 2010. Mr. Jones’ 35 year career in professional accounting at KPMG LLP included the role of Managing Partner at their Nashville, Tennessee office from 1999 to 2006. He served in various capacities during his career at KPMG which also included positions at their offices in Jackson, Mississippi, Washington, D.C. and Greenville, South Carolina. During his tenure with KPMG, Mr. Jones led a team of more than 100 individuals providing accounting services for an extensive client base. Following retirement in 2006, he has served as an advisor and provided various consulting services to several companies, including acting as liaison between management and the board of directors of a long-term care facility and serving as interim CEO of a charitable organization. He is currently a board director and member of the audit committee of Argent Trust Company of Tennessee. Mr. Jones also serves as a member of our Audit Committee and is our Audit Committee financial expert. Mr. Jones holds a B.S. from Mississippi College and an M.B.A from Mississippi State University. The Board believes Mr. Jones’ significant accounting background will strengthen Cumberland’s existing financial capabilities and play a key role as the Company is subject to increasingly stringent accounting and auditing regulations as a public entity.



Kenneth J. Krogulski
Director

Mr. Krogulski joined Cumberland’s Board of Directors in 2017. He has over 38 years of experience in security analysis and portfolio management and is currently the President and Chief Executive Officer of Berkshire Asset Management, LLC, as well as the company’s Chief Investment Officer. Berkshire is a 30-year-old independent SEC registered Pennsylvania based investment advisory firm with over $1.7 billion in assets under supervision. Prior to Berkshire, Mr. Krogulski began his career in financial services in 1979 at First Eastern Bank, N.A., now PNC Financial, as an investment analyst and portfolio manager, where he advanced to Chief Investment Officer of the Trust Department. He then joined Berkshire in 1990 and later led a management buy-out acquiring the company from Legg Mason. Under his leadership Berkshire’s assets under supervision have grown from $600 million in 2006 and are now over $1.7 billion. Currently Mr. Krogulski serves on the board of Allied Services Rehabilitation Hospital and as Chairman of the Appleseed Foundation. Previously he served as the Director of the Wyoming Valley Health Care System, on the board of the F.M. Kirby Center for the Performing Arts, the Luzerne Foundation and on various other community boards. Mr. Krogulski earned his M.B.A. from Wilkes University and a B.S. in finance from Indiana University of Pennsylvania. In addition, he holds the Chartered Financial Analyst designation



Caroline R. Young
Director

Ms. Young joined our Board in 2016. Caroline is the prior President of the Nashville Health Care Council and founding Executive Director of the Tennessee Biotechnology Association. She was the President of the Nashville Health Care Council from 2008 to 2015. The Council was formed as an association of the largest concentration of healthcare companies in the U.S., which are headquartered in the Nashville area. It is one of the nation’s foremost health care industry associations, and under Caroline’s leadership, membership grew to encompass 300 diverse organizations. There, she oversaw a series of international trade missions and launched one-of-a-kind Health Care Council Fellows program, designed to encompass the healthcare perspective and further develop the skills of senior business executives. Additionally, she expanded the Council’s innovative Leadership Health Care program, dedicated to nurturing the talents of the next generation of health care industry leaders. Prior to the Council, Caroline was the founding Executive Director of Tennessee Biotechnology Association (now Life Science Tennessee) from 2002 to 2004. She also served in communications roles for the State of Tennessee’s Department of Economic and Community Development from 1998 to 2002. Currently, Caroline is the Executive Director of NashvilleHealth, an initiative focused on improving the health of citizens of the metropolitan Nashville area of Tennessee. NashvilleHealth was founded by former U.S. Senate Majority Leader Bill Frist with the support from the Robert Wood Johnson Foundation. Caroline has been recognized by the Nashville Business Journal as a “Healthcare Hero,” and the Nashville Medical News as a “Woman to Watch.”